A rhabdomyolysis and metabolic myopathy gene panel (Invitae) was obtained inpatient and ultimately identified a pathogenic multiexon deletion of exons 3–9 and a second variant of uncertain significance (c.187G > T; p.Gly63Cys) in the TANGO2 gene. This evidence concerns the gene TANGO2 and rhabdomyolysis.